CV Sciences (CVSI) Capital Expenditures Growth (1y) (2014 - 2026)
CV Sciences (CVSI) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -85.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.71% |
| Mar 31, 2026 | -92.50% |
| Dec 31, 2025 | -50.00% |
| Mar 31, 2021 | -53.95% |
| Dec 31, 2020 | -27.35% |
| Sep 30, 2020 | -820.69% |
| Jun 30, 2020 | 760.00% |
| Dec 31, 2019 | 26.09% |
| Jun 30, 2019 | 136.23% |
| Dec 31, 2018 | 99.51% |
| Jun 30, 2018 | -2,252.89% |
| Sep 30, 2016 | 1,720,600.00% |
| Dec 31, 2015 | -76.80% |
| Sep 30, 2015 | -100.00% |
| Jun 30, 2015 | -92.53% |
| Mar 31, 2015 | 703.64% |
| Dec 31, 2014 | 299.53% |
| Sep 30, 2014 | -27.30% |
| Jun 30, 2014 | 1,101.41% |